<DOC>
	<DOCNO>NCT00044278</DOCNO>
	<brief_summary>This study evaluate long-term safety LAMICTAL ( lamotrigine ) subject partial seizure previously enrol protocol LAM20006 subject 1-24 month age never receive LAMICTAL ( LAMICTAL-naive ) . For LAMICTAL-naive subject , LAMICTAL add subject 's current epilepsy medication .</brief_summary>
	<brief_title>Pediatric Epilepsy Study Subjects 1-24 Months</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<criteria>Inclusion criterion : Must complete OpenLabel Phase protocol LAM20006 meet criterion LAMICTAL naive subject follow : A confident diagnosis epilepsy . 4 partial seizure per month . current treatment 1 2 antiepileptic drug . Exclusion criterion : Has seizure relate epilepsy . Has surgically implant functioning vagal nerve stimulator . Has previously treat lamotrigine . Is currently take felbamate , ACTH ( adrenocorticotrophic hormone ) ketogenic diet . Use experimental medication within 30 day enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>24 Months</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>epilepsy</keyword>
	<keyword>pediatric</keyword>
	<keyword>partial seizure</keyword>
</DOC>